Fierce Healthcare Women of Influence). Further solidifying her influence, Directors & Boards publication recognized Ms. Abbott as a Racial and Ethnic Director to Watch in 2022 (https://www.directorsandboards.com/articles/singledirectors-watch-2022-racial-ethnic-diversity).
Ms. Abbott’s expertise extends to corporate governance, as evidenced by her board service. She currently serves on the board of The Ensign Group, Inc. (ENSG), where she chairs the Compensation Committee and contributes to the Audit Committee and the Quality & Compliance Committee. Additionally, she holds a board position at Prognos, a private lab data analytics company, chairing the Audit Committee. Previously, Ms. Abbott served on the board of Magellan Health, Inc. (MGLN) until its acquisition by Centene in January 2022, where she chaired the Nominating and Governance Committee and served on the Quality & Compliance Committee. Her industry insights are also leveraged by the University of Chicago, where she is a member of the Industry Advisory Group.
Experience
BHI: April 2011 to March 2022
President & CEO – 2011 to March 2022
Blue Health Intelligence (BHI), an independent for-profit company backed by 18 Blue Cross Blue Shield plans and the Blue Cross Blue Shield Association (BCBSA), benefited significantly from Ms. Abbott’s leadership. BHI manages the largest medical and pharmacy claims database in the United States, with a mission focused on leveraging data and advanced analytics to enhance healthcare outcomes and control costs. This aligns perfectly with the goals of firms like Leavitt Equity Partners, who are keen on investing in companies that drive efficiency and value in healthcare.
Upon assuming leadership at BHI, which had spun out from BCBSA with $25M in annual expenses and no revenue, Ms. Abbott formulated a strategic business plan and secured $38M in capital from 18 Blue Cross Blue Shield plans. Her strategic vision and operational prowess propelled BHI to profitability within three years. Under her guidance, BHI evolved into a leading provider of data, analytical consulting, and software solutions for payers, providers, and life sciences companies, achieving revenues exceeding $60M in 2021. The company witnessed remarkable growth under her tenure, with over 400% increase in both revenue and profit.
As CEO of BHI, Ms. Abbott acted as a trusted advisor to Blue Cross Blue Shield CEOs and senior executives. She collaborated closely with the Blues and BCBSA, utilizing data and advanced analytics to enhance provider transparency, establish high-performance networks, and assess the effectiveness of value-based care models. Her experience in scaling and strategically positioning BHI underscores her capability to drive substantial growth and profitability, qualities highly valued by investment firms such as Leavitt Equity Partners.
Reed Elsevier: February 2003 to March 2011
VP Payer/Provider Solutions, Elsevier Health Sciences
President, MEDai and Informed Decisions
During her tenure at Reed Elsevier, Ms. Abbott held key leadership positions, including VP Payer/Provider Solutions for Elsevier Health Sciences and President of MEDai and Informed Decisions. MEDai, a predictive analytics company focused on integrated care management, experienced explosive growth under her leadership, with revenues increasing by 300% in just four years. Her strategic acumen was instrumental in the acquisition of MEDai by Reed Elsevier in 2008. Following the acquisition, Ms. Abbott took on the role of CEO for multiple companies acquired by Reed Elsevier, playing a pivotal role in building and expanding Reed Elsevier’s healthcare analytics business. This experience demonstrates her skill in not only growing companies organically but also successfully integrating acquisitions and expanding business lines, relevant expertise for private equity growth strategies.
ViPS, Inc.: December 2000 to January 2003
Managing Director, Medical Management Strategic Business Unit: 2000 to 2003
At ViPS, Inc., a provider of data warehousing and quality improvement solutions for payers, Ms. Abbott served as Managing Director for the Medical Management Strategic Business Unit. She held full P&L responsibility for this business line, focusing on aligning product development, implementation, and customer service teams with strategic market and customer demands. Her role at ViPS highlights her capability to manage and strategically direct business units within larger organizations, ensuring customer-centric approaches and market alignment.
HealthObjects Corporation: August 1998 to December 2000
Director, Product Management, Services and IT
As Director of Product Management, Services, and IT at HealthObjects Corporation, a subsidiary of Genesis Health Ventures, Ms. Abbott led critical functions to automate long-term care pharmacy operations and workflow. Her leadership in product management, customer service, and IT at HealthObjects demonstrates her ability to drive operational efficiency and technological innovation within healthcare service organizations.
SoftMed Systems, Inc: June 1995 to July 1998
Product Line Director
At SoftMed Systems, Inc., a leading provider of medical records management solutions, Ms. Abbott served as Product Line Director, leading the product team for coding/abstracting and clinical software. This software was utilized across various hospital departments nationwide. Her experience at SoftMed showcases her expertise in managing product lines for complex healthcare software solutions, catering to diverse needs within hospital environments.
Research Management Consultants, Inc: 1989 to 1995
Branch Manager, Consulting
Earlier in her career, Ms. Abbott was a Branch Manager at Research Management Consultants, Inc., where she led consulting projects for government agencies including the Department of Agriculture, FAA, and National Park Service. This early experience in consulting, across diverse sectors, provided a foundation for her strategic and analytical approach to business challenges.
EDUCATION
B.S. Physics, Delhi University
Swati Abbott’s extensive experience and proven leadership in healthcare data analytics and strategic growth position her as an exceptional leader, whose skills and expertise would be highly valuable to firms like Leavitt Equity Partners and their portfolio companies within the healthcare sector.
